LG Chem partners with UK's LabGenius on AI cancer drugs
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-06-18 14:19 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Science, Health, Europe, Technology & AI, Drugs, World News, Technology
--------------------------------------------------------------------
Snippet:
LG Chem said Thursday it signed a joint research and license option agreement with UK-based biotechnology company LabGenius Therapeutics to develop next-generation multispecific antibody therapies for cancer using artificial intelligence.
--------------------------------------------------------------------